A citation-based method for searching scientific literature

Eric B Meltzer, Paul W Noble. Orphanet J Rare Dis 2008
Times Cited: 245







List of co-cited articles
559 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
46

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
27

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
25

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
22

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
22

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
985
21

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
876
20


Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
14

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
499
13

Incidence and prevalence of idiopathic pulmonary fibrosis.
Ganesh Raghu, Derek Weycker, John Edelsberg, Williamson Z Bradford, Gerry Oster. Am J Respir Crit Care Med 2006
799
11


Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
343
10

Classification and natural history of the idiopathic interstitial pneumonias.
Dong Soon Kim, Harold R Collard, Talmadge E King. Proc Am Thorac Soc 2006
255
10

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
882
10

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
10


Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.
Amy L Olson, Jeffrey J Swigris, Dennis C Lezotte, Jill M Norris, Carla G Wilson, Kevin K Brown. Am J Respir Crit Care Med 2007
292
8

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Roland M du Bois, Elizabeth A Fagan, Robert S Fishman, Ian Glaspole, Marilyn K Glassberg, Lisa Lancaster,[...]. Eur Respir J 2016
209
8

The rising incidence of idiopathic pulmonary fibrosis in the U.K.
V Navaratnam, K M Fleming, J West, C J P Smith, R G Jenkins, A Fogarty, R B Hubbard. Thorax 2011
299
7

Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.
Evans R Fernández Pérez, Craig E Daniels, Darrell R Schroeder, Jennifer St Sauver, Thomas E Hartman, Brian J Bartholmai, Eunhee S Yi, Jay H Ryu. Chest 2010
271
7

The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.
Benjamin D Bringardner, Christopher P Baran, Timothy D Eubank, Clay B Marsh. Antioxid Redox Signal 2008
181
7

Pathogenesis of idiopathic pulmonary fibrosis.
Paul J Wolters, Harold R Collard, Kirk D Jones. Annu Rev Pathol 2014
374
7



Mechanisms of fibrosis: therapeutic translation for fibrotic disease.
Thomas A Wynn, Thirumalai R Ramalingam. Nat Med 2012
6

Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis.
Baruch Vainshelboim, Jose Oliveira, Liora Yehoshua, Israela Weiss, Benjamin Daniel Fox, Oren Fruchter, Mordechai Reuven Kramer. Respiration 2014
72
8

Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.
Baruch Vainshelboim, Jose Oliveira, Benjamin Daniel Fox, Yafit Soreck, Oren Fruchter, Mordechai Reuven Kramer. Lung 2015
57
10

Idiopathic pulmonary fibrosis.
T J Gross, G W Hunninghake. N Engl J Med 2001
725
6

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
Ganesh Raghu, Shih-Yin Chen, Wei-Shi Yeh, Brad Maroni, Qian Li, Yuan-Chi Lee, Harold R Collard. Lancet Respir Med 2014
318
6

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.
Luba Nalysnyk, Javier Cid-Ruzafa, Philip Rotella, Dirk Esser. Eur Respir Rev 2012
276
6

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
641
6

Patient experiences with pulmonary fibrosis.
Harold R Collard, Gregory Tino, Paul W Noble, Mark A Shreve, Maureen Michaels, Bruce Carlson, Marvin I Schwarz. Respir Med 2007
73
8

A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
617
6

Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis.
Gareth Hughes, Hannah Toellner, Helen Morris, Colm Leonard, Nazia Chaudhuri. J Clin Med 2016
96
6

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.
Kevin K Kim, Matthias C Kugler, Paul J Wolters, Liliane Robillard, Michael G Galvez, Alexis N Brumwell, Dean Sheppard, Harold A Chapman. Proc Natl Acad Sci U S A 2006
895
6

Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
326
6

Is idiopathic pulmonary fibrosis an environmental disease?
Varsha S Taskar, David B Coultas. Proc Am Thorac Soc 2006
193
6

Murine models of pulmonary fibrosis.
Bethany B Moore, Cory M Hogaboam. Am J Physiol Lung Cell Mol Physiol 2008
500
5


Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.
J J Swigris, W G Kuschner, S S Jacobs, S R Wilson, M K Gould. Thorax 2005
163
5


An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.
Martijn A Spruit, Sally J Singh, Chris Garvey, Richard ZuWallack, Linda Nici, Carolyn Rochester, Kylie Hill, Anne E Holland, Suzanne C Lareau, William D-C Man,[...]. Am J Respir Crit Care Med 2013
5

Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation.
Jeffrey J Swigris, Kevin K Brown, Barry J Make, Frederick S Wamboldt. Respir Med 2008
52
9

Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients.
Gadi Schoenheit, Ian Becattelli, Alan H Cohen. Chron Respir Dis 2011
84
5

Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature.
Kristin D Kistler, Luba Nalysnyk, Philip Rotella, Dirk Esser. BMC Pulm Med 2014
74
6

Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events.
Ulrich Costabel, Elisabeth Bendstrup, Vincent Cottin, Pieter Dewint, Jim J J Egan, James Ferguson, Richard Groves, Per M Hellström, Michael Kreuter, Toby M Maher,[...]. Adv Ther 2014
80
6

Epidemiology of idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard. Clin Epidemiol 2013
153
5

Lung volumes and forced ventilatory flows.
P H Quanjer, G J Tammeling, J E Cotes, O F Pedersen, R Peslin, J C Yernault. Eur Respir J 1993
5

Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.
Ulrich Costabel, Yoshikazu Inoue, Luca Richeldi, Harold R Collard, Inga Tschoepe, Susanne Stowasser, Arata Azuma. Am J Respir Crit Care Med 2016
151
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.